This single ingredient is what allows for a multi-use vial
Store at -20C protected from moisture and light
Compounding BPC-157: A regulatory loophole In a statement, Health Canada said "BPC157 has not been authorized, its safety, efficacy, and quality have not been assessed and there is limited scientific evidence to support its use, including a lack of established human dosing protocols." In addition, the regulator says BPC-157 is not approved for use in any NHPs in any form, including oral and injectable, but it can still be compounded for topical use or oral administration as an NHP
The absence of growth hormone-related side effects, no impact on glucose metabolism or IGF-1, and favorable comparison to other fat loss interventions make it a valuable option for appropriate individuals
You can rest assured that your comfort and safety are our top priorities throughout the process
Vitamin B12 (Cobalamin) Deficiency in Elderly Patients. Canadian Medical Association Journal 171, no